San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

This revolution is being powered by RNA technology—and Canada is uniquely positioned to lead it. While the swift development ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph ...

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph, it was ...